Patent US1400816A successfully refreshed from Google Patents.
Patent US5141752A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5141752A Expired / Lapsed US ⏱️ 0.0 years remaining

Delayed drug delivery device

Assignee: Alza Corp
•
Filing: 1991-07-25
•
Granted: 1992-08-25
•
Expires: 2011-07-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.

Inventors

  • 👤 Atul D. Ayer
  • 👤 Felix Theeuwes
  • 👤 Patrick S. L. Wong

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 18:11
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 155 words
A dosage form for delivering a beneficial drug formulation to an environment of use, the dosage form comprising: (a) a wall comprising at least in part a semipermeable composition permeable to the passage of an external fluid present in the environment of use and substantially impermeable to the passage of a beneficial drug formulation, which wall surrounds and forms; (b) a compartment; (c) a drug formulation in the compartment that exhibits an osmotic pressure gradient across a semipermeable wall, which drug formulation produces at least one of a physiological, pharmacological, local and systemic effect in an animal; (d) means for delaying the delivery of the drug formulation up to 12 hours from the compartment, which means comprises a drug-free lamina that surrounds the drug formulation; and, (e) at least one exit means in the wall for communicating the exterior of the dosage form with the compartment for delivering the dosage formulation from the dosage form.
Claim 2
Dependent Claim 155 words
A dosage form for delivering a beneficial drug formulation to an environment of use, the dosage form comprising: (a) a wall comprising at least in part a semipermeable composition permeable to the passage of an external fluid present in the environment of use and substantially impermeable to the passage of a beneficial drug formulation, which wall surrounds and forms; (b) a compartment; (c) a drug formulation in the compartment that exhibits an osmotic pressure gradient across a semipermeable wall, which drug formulation produces at least one of a physiological, pharmacological, local and systemic effect in an animal; (d) means for delaying the delivery of the drug formulation up to 12 hours from the compartment, which means comprises a drug-free lamina that surrounds the drug formulation; and, (e) at least one exit means in the wall for communicating the exterior of the dosage form with the compartment for delivering the dosage formulation from the dosage form.

References Cited (Backward Citations)

US4842867A Cited
US4948592A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-08-25 1996-02-24 1996-08-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-08-25 2000-02-24 2000-08-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-08-25 2004-02-24 2004-08-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag